These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24358069)

  • 1. The Effect of Socioeconomic Class and Immigrant Status on Disease Activity in Rheumatoid Arthritis: Data from BARFOT, a Multi-Centre Study of Early RA.
    Andersson ML; Bergman S; Söderlin MK
    Open Rheumatol J; 2013; 7():105-11. PubMed ID: 24358069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J
    Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Stopping Smoking on Disease Activity in Rheumatoid Arthritis (RA). Data from BARFOT, a Multicenter Study of Early RA.
    Andersson ML; Bergman S; Söderlin MK
    Open Rheumatol J; 2012; 6():303-9. PubMed ID: 23115602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking at onset of rheumatoid arthritis (RA) and its effect on disease activity and functional status: experiences from BARFOT, a long-term observational study on early RA.
    Söderlin MK; Petersson IF; Bergman S; Svensson B;
    Scand J Rheumatol; 2011; 40(4):249-55. PubMed ID: 21338325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of snuff (smokeless tobacco) on disease activity and function in rheumatoid arthritis: experiences from the Better Anti-Rheumatic FarmacOTherapy, a longitudinal multicenter study on early rheumatoid arthritis.
    Andersson ML; Bergman S; Söderlin MK;
    J Clin Rheumatol; 2013 Jan; 19(1):14-8. PubMed ID: 23319018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-hand exposure to tobacco smoke and its effect on disease activity in Swedish rheumatoid arthritis patients. Data from BARFOT, a multicenter study of RA.
    Söderlin MK; Andersson M; Bergman S;
    Clin Exp Rheumatol; 2013; 31(1):122-4. PubMed ID: 23101488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
    Khawaja MN; Bergman MJ; Yourish J; Pei J; Reiss W; Keystone E
    Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of progression to rheumatoid arthritis: discriminative value of the new ACR/EULAR rheumatoid arthritis criteria in a Portuguese population with early polyarthritis.
    Mourão AF; Canhão H; Moura RA; Cascão R; Weinmann P; Rodrigues A; Polido-Pereira J; Resende C; Capela S; Silva JA; Fonseca JE
    Acta Reumatol Port; 2011; 36(4):370-6. PubMed ID: 22472927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study.
    Choi S; Lee KH
    PLoS One; 2018; 13(4):e0195550. PubMed ID: 29624625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab for refractory rheumatoid arthritis: a 24-week open-label prospective study.
    Ho LY; Mok CC; To CH; Anselm M; Cheung MY; Yu KL
    Open Rheumatol J; 2007; 1():1-4. PubMed ID: 19088893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.
    Wells G; Becker JC; Teng J; Dougados M; Schiff M; Smolen J; Aletaha D; van Riel PL
    Ann Rheum Dis; 2009 Jun; 68(6):954-60. PubMed ID: 18490431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pain score measured by a visual analog scale (PS-VAS) on the Health Assessment Questionnaire Disability Index and 28-joint Disease Activity Index with C-reactive protein in rheumatoid arthritis patients.
    Yoshii I; Chijiwa T; Sawada N
    Int J Rheum Dis; 2018 Nov; 21(11):1955-1961. PubMed ID: 30175554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Work instability and associated factors among patients with rheumatoid arthritis in Greater Poland.
    Schmidt W; Tąpolska M; Pawlak-Buś K; Owczarek M; Leszczyński P
    Reumatologia; 2020; 58(4):208-212. PubMed ID: 32921827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absent "Window of Opportunity" in smokers with short disease duration. Data from BARFOT, a multicenter study of early rheumatoid arthritis.
    Söderlin MK; Bergman S;
    J Rheumatol; 2011 Oct; 38(10):2160-8. PubMed ID: 21807778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.
    Pease C; Pope JE; Truong D; Bombardier C; Widdifield J; Thorne JC; Paul Haraoui B; Psaradellis E; Sampalis J; Bonner A
    Semin Arthritis Rheum; 2011 Aug; 41(1):81-9. PubMed ID: 21168187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study.
    Verschueren P; Esselens G; Westhovens R
    Scand J Rheumatol; 2009; 38(3):166-72. PubMed ID: 19169906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic widespread pain in patients with rheumatoid arthritis and the relation between pain and disease activity measures over the first 5 years.
    Andersson ML; Svensson B; Bergman S
    J Rheumatol; 2013 Dec; 40(12):1977-85. PubMed ID: 24187108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of anti-cyclic citrullinated peptide antibodies with clinical and radiological disease severity in rheumatoid arthritis.
    Gupta A; Kaushik R; Kaushik RM; Saini M; Kakkar R
    Curr Rheumatol Rev; 2014; 10(2):136-43. PubMed ID: 25599684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sources of discrepancy in patient and physician global assessments of rheumatoid arthritis disease activity.
    Nicolau G; Yogui MM; Vallochi TL; Gianini RJ; Laurindo IM; Novaes GS
    J Rheumatol; 2004 Jul; 31(7):1293-6. PubMed ID: 15229946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.